Heritage Pharmaceuticals Pays Over $7 Million to Resolve Civil False Claims Act Allegations
PHILADELPHIA, PA - United States Attorney William M. McSwain today announced that generic drug manufacturer Heritage Pharmaceuticals, Inc. will pay over $7 million in a civil settlement to resolve allegations of a scheme to fix prices and allocate customers for several of its drugs. The civil resolution of these allegations in the Eastern District is a component of the company's larger resolution with the Department of Justice's (DOJ) Antitrust Division and Civil Division.
- Date:May 31, 2019
- Agency:U.S. Attorney
- Criminal and Civil Actions